U.S. market Closed. Opens in 2 days 12 hours 7 minutes

AMPE | Ampio Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: AMEX)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
RevenueN/AN/AN/AN/AN/AN/AN/AN/A1.16M76.79K50.00K50.00K18.75KN/AN/AN/AN/AN/A
Cost of Revenue250.00K2.08M1.09M1.18M1.27M523.00K568.00K950.00K369.31K2.24M1.74M1.45MN/AN/AN/A950.00N/AN/A
Gross Profit-250.00K-2.08M-1.09M-1.18M-1.27M-523.00K-568.00K-950.00K793.15K-2.16M-1.69M-1.40M18.75KN/AN/A-950.00N/AN/A
Operating Expenses9.27M20.38M20.57M15.83M18.58M11.18M15.56M17.08M34.10M39.15M24.07M11.87M11.15M6.70M21.87K29.23K29.00K1.00K
Selling, General & Admin7.08M11.47M8.67M6.65M5.90M4.36M5.14M6.54M15.13M12.22M5.79M4.38M4.50M4.73M21.87K28.28K27.80KN/A
Research & Development2.44M8.92M11.90M9.17M12.62M6.83M10.42M10.55M18.96M26.92M18.29M7.49M6.65M1.97M1.07MN/AN/AN/A
Other Operating ExpensesN/A1.94MN/A12.00K56.00KN/A323.55K143.80KN/AN/AN/AN/A34.01KN/AN/A950.001.20KN/A
Operating Income-9.52M-24.21M-25.16M-15.22M-23.45M-11.18M-15.56M-17.08M-33.30M-39.07M-24.02M-11.82M-11.13M-6.70M-21.87K-29.23K-29.00K-1.00K
Other Expenses / Income886.00K4.04M3.50M-60.00K4.95M45.17M-36.22M-2.08M-412.07K-7.60M-504.16K227.29K-7.14M-1.35M-4.18K-2.65K-2.19KN/A
Before Tax Income-8.63M-16.34M-17.07M-15.89M-13.63M33.99M-51.89M-19.16M-33.71M-39.05M-24.53M-11.59M-18.28M-8.05M-26.05K-31.88K-31.20KN/A
Income Tax ExpensesN/A-7.87M-4.59M604.00K-4.95M45.17M36.33M1.04M-1.29M-923.52K-519.87K-68.0082.50K18.73KN/AN/A800.001.00K
Net Income-8.63M-8.47M-12.48M-16.50M-8.68M33.99M-51.89M-19.16M-32.01M-38.13M-24.01M-11.59M-18.36M-8.05M-26.05K-31.88K-32.00K-1.00K
Interest ExpensesN/AN/AN/AN/A77.00KN/AN/AN/AN/AN/AN/AN/A8.36K19.55K4.18K2.65KN/AN/A
Basic Shares Outstanding809.00K753.62K664.33K576.15K474.03K369.00K217.00K179.00K173.31K167.42K127.65K113.28K86.71K58.55K49.31K61.98K61.98K61.98K
Diluted Shares Outstanding810.11K753.62K671.49K595.41K474.03K369.81K217.66K179.24K173.31K167.42K127.65K113.28K86.71K58.55K49.31K61.98K61.98K61.98K
EBITDAN/A-18.30MN/AN/A-17.30M35.26M-14.46M-14.81M-23.34MN/A-23.89M-11.76M-11.08M-8.01M-21.87K-29.23K-26.81K-1.00K
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-2,008.05%0.00%-47,772.39%-23,515.88%-59,119.50%0.00%0.00%0.00%0.00%0.00%
EBIT-8.63M-16.34M-17.07M-15.89M-13.55M79.16M-15.56M-18.13M-33.30M-39.05M-24.53M-11.59M-18.27M-8.02M-21.87K-29.23K-31.20KN/A
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%-2,864.82%-50,853.58%-49,056.85%-23,186.23%-97,431.34%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙